日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rifamycin O as a novel CRBN ligand for targeted degradation of IKZF1/3 proteins in hematopoietic malignancies

利福霉素 O 作为一种新型 CRBN 配体,用于靶向降解造血系统恶性肿瘤中的 IKZF1/3 蛋白

Liao, Liang; Wang, Qiang; Gao, Zhengyang; Liu, Jiayao; Tong, Yuxuan; Chen, Xin; Zhu, Jin; Li, Jian; Wei, Jinlian

High-dose irradiation promotes macrophage-mediated engulfment of triple-negative breast cancer through M1 polarization via the IKZF1-CCL5 axis.

高剂量辐射通过 IKZF1-CCL5 轴促进巨噬细胞介导的 M1 极化,从而吞噬三阴性乳腺癌。

Kuo Han-Hsi, Chan Hui-Wen, Liu Chun-Yu, Chen Ming-Huang, Lee Yi-Jang, Chuang Hui-Yen, Chang Yu-Chan

Manipulation of Alternative Splicing of IKZF1 Elicits Distinct Gene Regulatory Responses in T Cells.

操纵 IKZF1 的选择性剪接可引起 T 细胞中不同的基因调控反应。

A novel human acute myeloid leukemia cell line SDEY-AML1 with KMT2A: MLLT3, IKZF1: EVX1 fusions exhibits high tumorigenicity in NSG mice

一种新型人急性髓系白血病细胞系SDEY-AML1,携带KMT2A:MLLT3和IKZF1:EVX1融合基因,在NSG小鼠中表现出高致瘤性。

Yang, Chenwei; Zhang, Weiliang; Wu, Yijun; Liu, Xin; Gao, Li; Zhang, Hui; Li, Zhiheng; Hu, Shaoyan

TNFSF4/OX40L and IKZF1/IKAROS Genetic Variant Associations with Egyptian Juvenile Systemic Lupus Erythematosus (JSLE)

TNFSF4/OX40L 和 IKZF1/IKAROS 基因变异与埃及青少年系统性红斑狼疮 (JSLE) 的关联

Attia, Zeinab R; Amshawee, Ahmed M; Hasan, Ahmed Flayyih; Hussein, Dalia Tawfeek; Abd El Azeem, Rania A; Zedan, Mohamed M; Mutawi, Thuraya M; El-Beltagy, Nanis S; El Basuni, Mohamed A

Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia

IKZF1基因组改变的异质性与儿童B细胞前体急性淋巴细胞白血病的复发风险

Wang'ondu, Ruth W; Ashcraft, Emily; Chang, Ti-Cheng; Roberts, Kathryn G; Brady, Samuel W; Fan, Yiping; Evans, William; Relling, Mary V; Crews, Kristine R; Yang, Jun; Yang, Wenjian; Pounds, Stanley; Wu, Gang; Devidas, Meenakshi; Maloney, Kelly; Mattano, Leonard; Schore, Reuven J; Angiolillo, Anne; Larsen, Eric; Salzer, Wanda; Burke, Michael J; Loh, Mignon L; Jeha, Sima; Pui, Ching-Hon; Inaba, Hiroto; Cheng, Cheng; Mullighan, Charles G

Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma

在多发性骨髓瘤细胞疗法中,通过调节 E3 连接酶底物来靶向降解 IKZF1 和 IKZF3。

Kegyes, David; Bancos, Anamaria; Tigu, Adrian Bogdan; Rus, Ioana; Dima, Delia; Cenariu, Diana; Nistor, Madalina; Munteanu, Raluca; Gulei, Diana; Tanase, Alina; Colita, Anca; Buzoianu, Anca; Iuga, Cristina; Zdrenghea, Mihnea; Terpos, Evangelos; Ciurea, Stefan O; Ciechanover, Aaron; Einsele, Hermann; Tomuleasa, Ciprian

IKZF1 as a potential therapeutic target for dendritic cell-mediated immunotherapy in IgA nephropathy

IKZF1作为IgA肾病中树突状细胞介导免疫疗法的潜在治疗靶点

Fei Peng # ,Chunjia Sheng # ,Jiayi He # ,Yena Zhou ,Yilun Qu ,Shuwei Duan ,Yinghua Zhao ,Jikai Xia ,Jie Wu ,Guangyan Cai ,Lingling Wu ,Chuyue Zhang ,Xiangmei Chen

B-cell lymphoblastic leukemia/lymphoma with mutated IKZF1 N159Y: clinical and genetic features of an emerging entity

伴有IKZF1 N159Y突变的B细胞淋巴母细胞白血病/淋巴瘤:一种新兴疾病的临床和遗传特征

Alvey, Emily N; Yap, Kai Lee; Rathbun, Pamela; Fitzpatrick, Carrie; Gong, Shunyou; Richardson, Aida I

A new pipeline SPICE identifies novel JUN-IKZF1 composite elements

新的SPICE流程可识别新型JUN-IKZF1复合材料元件

Li, Peng; Pulugulla, Sree; Das, Sonali; Oh, Jangsuk; Spolski, Rosanne; Lin, Jian-Xin; Leonard, Warren J